Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christian H. Geisler
Observed names:
C Geisler,
C. Geisler,
C. H. Geisler,
C.H. Geisler,
Christian Geisler,
Christian H Geisler,
Christian Hartmann Geisler
show all 7
Institutions:
Copenhagen University Hospital,
Rigshospitalet
Observed institutions:
University of Copenhagen,
Karolinska University Hospital,
Copenhagen University Hospital,
Rigshospitalet,
Nordic Lymphoma Group,
Centro de Investigacion Principe Felipe,
Sapienza University of Rome
show all 7
OpenAlex ID:
A5113817714
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
2012
·
Andreas Agathangelidis
, Nikos Darzentas
, et al.
·
Blood
·
393
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
2014
·
Mohammed Z H Farooqui
, Janet Valdez
, et al.
·
The Lancet Oncology
·
372
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study
2018
·
Inhye E. Ahn
, Mohammed Z. H. Farooqui
, et al.
·
Blood
·
205
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study
1990
·
F. Pandolfi
, T. P. Loughran
, et al.
·
Cancer
·
161
PDF
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study
2014
·
Lena Nordström
, Sandra Sernbo
, et al.
·
British Journal of Haematology
·
134
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
2014
·
Panagiotis Baliakas
, Anastasia Hadzidimitriou
, et al.
·
The Lancet Haematology
·
113
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study
2015
·
Marinus H J van Oers
, Kazimierz Kuliczkowski
, et al.
·
The Lancet Oncology
·
112
In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients
1997
·
C.H. Geisler
, P. Philip
, et al.
·
Leukemia Research
·
112
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
2013
·
J C Strefford
, L-A Sutton
, et al.
·
Leukemia
·
104
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
2011
·
R. Gunnarsson
, L. Mansouri
, et al.
·
Haematologica
·
101
PDF
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia
2009
·
A Österborg
, R Foà
, et al.
·
Leukemia
·
89
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
2015
·
Panagiotis Baliakas
, Andreas Agathangelidis
, et al.
·
Blood
·
82
PDF
On the way towards a ‘CLL prognostic index’: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
2013
·
D Cortese
, L-A Sutton
, et al.
·
Leukemia
·
79
Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients
2016
·
C da Cunha-Bang
, J Simonsen
, et al.
·
Blood Cancer Journal
·
77
PDF
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
2012
·
L Mansouri
, N Cahill
, et al.
·
Leukemia
·
67
Treatment of hypogammaglobulinemia in chronic lymphocytic leukaemia by low‐dose intravenous gammaglobulin
1994
·
Jesper Jurlander
, Christian Hartmann Geisler
, et al.
·
European Journal Of Haematology
·
67
Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia
1994
·
Anders Mellemgaard
, Christian H. Geisler
, et al.
·
European Journal Of Haematology
·
65
PDF
Effect of FCGR2A and FCGR3A variants on CLL outcome
2010
·
David Dornan
, Olivia Spleiss
, et al.
·
Blood
·
62
The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia
1986
·
C. Geisler
, E. Ralfkiær
, et al.
·
British Journal of Haematology
·
59
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia
2007
·
Pär Josefsson
, Christian H. Geisler
, et al.
·
Blood
·
54
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death
2016
·
Michael Asger Andersen
, Fie Juhl Vojdeman
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
49
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
2018
·
Alexander C. Leeksma
, Justin Taylor
, et al.
·
Leukemia
·
48
PDF
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemia
2013
·
Alexander Jethwa
, Jennifer Hüllein
, et al.
·
British Journal of Haematology
·
47
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
2013
·
Larry Mansouri
, Pawel Grabowski
, et al.
·
American Journal of Hematology
·
47
PDF
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
2020
·
Christian Winther Eskelund
, Simon Husby
, et al.
·
Blood
·
44
Show more works
View as search
Works count:
105
Citation count:
3,386
H-index:
31
I10-index:
51
Year
Topic
Type
